Kunshan RiboQuark Pharmaceutical Technology Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$7.42M
- Investors
-
3
Kunshan RiboQuark Pharmaceutical Technology General Information
Description
Operator of clinical stage pharmaceutical company. The company specializes in development of therapies to address medical needs and additionally offers a ocular neuroprotectant which is used for the prevention of hair loss.
Contact Information
Corporate Office
- Kunshan
- China
Corporate Office
- Kunshan
- China
Kunshan RiboQuark Pharmaceutical Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 07-Jan-2014 | $7.42M | Completed | Startup | ||
| 1. Joint Venture | 01-Sep-2012 | Completed | Startup |
Kunshan RiboQuark Pharmaceutical Technology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BVCF | Venture Capital | Minority | ||
| Quark Pharmaceuticals | Corporation | Majority | ||
| Suzhou Ribobio Biotechnology | Corporation | Majority |
Kunshan RiboQuark Pharmaceutical Technology FAQs
-
When was Kunshan RiboQuark Pharmaceutical Technology founded?
Kunshan RiboQuark Pharmaceutical Technology was founded in 2012.
-
Where is Kunshan RiboQuark Pharmaceutical Technology headquartered?
Kunshan RiboQuark Pharmaceutical Technology is headquartered in Kunshan, China.
-
What industry is Kunshan RiboQuark Pharmaceutical Technology in?
Kunshan RiboQuark Pharmaceutical Technology’s primary industry is Drug Discovery.
-
Is Kunshan RiboQuark Pharmaceutical Technology a private or public company?
Kunshan RiboQuark Pharmaceutical Technology is a Private company.
-
What is Kunshan RiboQuark Pharmaceutical Technology’s current revenue?
The current revenue for Kunshan RiboQuark Pharmaceutical Technology is .
-
How much funding has Kunshan RiboQuark Pharmaceutical Technology raised over time?
Kunshan RiboQuark Pharmaceutical Technology has raised $7.42M.
-
Who are Kunshan RiboQuark Pharmaceutical Technology’s investors?
BVCF, Quark Pharmaceuticals, and Suzhou Ribobio Biotechnology have invested in Kunshan RiboQuark Pharmaceutical Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process